1-[(Oxolan-3-yl)methyl]-1H-imidazole

Catalog No. :
ACTSAG965
CAS No. :
1343676-23-2
Molecular Formula :
C8H12N2O
Molecular Weight :
152.20

IUPAC Name:1-((tetrahydrofuran-3-yl)methyl)-1H-imidazole

1-[(Oxolan-3-yl)methyl]-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$113.00Login to see priceInquiryInquiry
100mg95%$159.00Login to see priceInquiryInquiry
250mg95%$220.00Login to see priceInquiryInquiry
1g95%$536.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(Oxolan-3-yl)methyl]-1H-imidazole
IUPAC Name1-((tetrahydrofuran-3-yl)methyl)-1H-imidazole
MDL No.MFCD18840760
Molecular FormulaC8H12N2O
Molecular Weight152.20
SMILESN1(CC2COCC2)C=CN=C1
InChI KeyKVKKBNYHDZXQJS-UHFFFAOYSA-N
Synonym1-[(oxolan-3-yl)methyl]-1H-imidazole;1-[(Tetrahydro-3-furanyl)methyl]-1H-imidazole;1H-Imidazole, 1-[(tetrahydro-3-furanyl)methyl]-
CAS No.1343676-23-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTSAG965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYVSC702 route compound structure diagram
    ACYVSC702165253-29-2 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACTSAG965 route product structure diagram
    ACTSAG9651343676-23-2
Inquiry

2. ACTSAG965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACTSAG965 route product structure diagram
    ACTSAG9651343676-23-2
Inquiry

Comments (0)